HomeVXL • CVE
add
Vaxil Bio Ltd
Previous close
$0.010
Year range
$0.0050 - $0.035
Market cap
1.37M CAD
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 49.00K | -61.42% |
Net income | -49.00K | 61.42% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 589.00K | -44.64% |
Total assets | 863.00K | -23.02% |
Total liabilities | 76.00K | -67.52% |
Total equity | 787.00K | — |
Shares outstanding | 136.98M | — |
Price to book | 1.00 | — |
Return on assets | -13.64% | — |
Return on capital | -15.10% | — |
Cash Flow
Net change in cash
| (CAD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -49.00K | 61.42% |
Cash from operations | -80.00K | 71.33% |
Cash from investing | -250.00K | — |
Cash from financing | — | — |
Net change in cash | -331.00K | -19.06% |
Free cash flow | -311.62K | -34.10% |
About
Founded
2006
Headquarters
Website
